Linked Life Data

7604758

Source:http://linkedlifedata.com/resource/pubmed/id/7604758

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1995-8-10
pubmed:abstractText
An open multicentre clinical trial of inhaled B-agonist, salmeterol, was carried out to assess its efficacy in adult Nigerian asthmatic patients. Seventy-four patients were recruited to the trial and 64 (86.48%) completed the trials. 50mcg of inhaled salmeterol was administered to the patients twice a day over a period of 2 weeks. The patients were assessed on weekly basis, at week 1, 2 and 3 subjectively and objectively using the protocol prepared by the sponsor of the study. Salmeterol was found to reduce symptoms of asthma considerably, both at day time and at night. The patient's tolerance to exercise improved significantly. The lung function assessed using Peak Expiratory Flow Meter (PEFR) showed significant improvement. Side effects were not encountered during the duration of the study. It was conclusively shown that overall, salmeterol is effective in the management of asthma in adult Nigerian patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0309-3913
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
301-5
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
An open multi-centre study to assess the efficacy of inhaled salmeterol in bronchial asthma in Nigeria.
pubmed:affiliation
Department of Medicine, University College Hospital, Ibadan, Nigeria.
pubmed:publicationType
Journal Article, Clinical Trial, Multicenter Study